Proteome Sciences Plc

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB0003104196
GBP
0.03
0.01 (69.7%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Kromek Group Plc
Tristel Plc
EKF Diagnostics Holdings Plc
Avon Protection Plc
Inspecs Group Plc
Creo Medical Group Plc
Advanced Medical Solutions Group Plc
Inspiration Healthcare Group Plc
Belluscura Plc
Proteome Sciences Plc
Tissue Regenix Group Plc
Why is Proteome Sciences Plc ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 7.03 times
2
Flat results in Dec 24
  • OPERATING CASH FLOW(Y) Lowest at GBP -1.3 MM
  • DEBT-EQUITY RATIO (HY) Highest at -205.52 %
  • RAW MATERIAL COST(Y) Grown by 98.18% (YoY)
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 7.69%, its profits have risen by 18.4%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Proteome Sciences Plc for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Proteome Sciences Plc
7.69%
-0.31
111.39%
FTSE 100
15.94%
1.23
12.99%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-1.07%
EBIT Growth (5y)
-208.01%
EBIT to Interest (avg)
-0.27
Debt to EBITDA (avg)
7.03
Net Debt to Equity (avg)
-1.90
Sales to Capital Employed (avg)
0.67
Tax Ratio
4.86%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.37%
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.67
EV to EBIT
-8.85
EV to EBITDA
-13.86
EV to Capital Employed
3.52
EV to Sales
4.43
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-39.80%
ROE (Latest)
Negative BV
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bullish
Bullish
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Bearish
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Here's what is working for Proteome Sciences Plc
Net Profit
Higher at GBP -1.19 MM
than preceding 12 month period ended Dec 2024
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (GBP MM)

Inventory Turnover Ratio
Highest at 6.44% and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Net Sales
At GBP 2.67 MM has Grown at 46.86%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (GBP MM)

Here's what is not working for Proteome Sciences Plc
Debt-Equity Ratio
Highest at -205.52 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Operating Cash Flow
Lowest at GBP -1.3 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (GBP MM)

Cash and Eqv
Lowest at GBP 1.13 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Raw Material Cost
Grown by 98.18% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales